期刊文献+

生殖道人乳头状瘤病毒基因型检测及临床分析 被引量:1

Clinical analysis of human papilloma virus genotype with genital
原文传递
导出
摘要 目的:讨论女性生殖道人乳头状瘤(HPV)感染的类型及临床意义。方法:采用反向寡核苷酸探针杂交技术(PCR-RDB)对1524例女性生殖道标本进行HPV分型检测,分析各型的感染率以及感染病毒与年龄段关系及HPV分型在宫颈病变中的意义。结果:1524分标本共检出HPV阳性279例总体阳性率为18.31%,PCR-RDB技术所涉及到的23种HPV基因型均被检出,其中高危型以16、185、85、2型为主,低危型以11、6型为主,多型混合感染多发生在15岁~25岁和46岁~55岁,随着宫颈糜烂程度的增加多重感染数量也增加。结论:女性生殖道HPV感染高危型以16、18型为主,低危以6、11为主;在预防和治疗宫颈病变时应重视HPV亚型的混合感染。 Objective:To discuss the type of human papillomavirus infection of female genital tract and its clinical significance.Methods:Using reverse oligonucleotide microarray probes hybridization techonology to typing test 1524 sepecimens of female genital tract,to analyze infection rates of various types,relationship between infection virus and age and the significance of HPV typing in cervical lesions.Results:There're 279 cases infected from HPV in 1524 sepecimens with 18.31% positive rate,23 kinds of HPV genotypes involve in PCR-RDB techonology were all detected,with 16,18,58,52 taking great important part in high-risk type and 11,6 in low-risk type.Types of mixde infection mainly ocurs in age of 15 to 25 and 46 to 55,and the number of multiplicity of infection increases with the degree of cervical erosion.Conclusion:In human papillomavirus infection of female genital tract,16,18 take important part in high-risk type and 11,6 in low-risk type;Mixed infection of HPV subtypes should be foucs in the prevention and treatment of cervical lesions.
出处 《中国卫生检验杂志》 CAS 2011年第3期688-689,共2页 Chinese Journal of Health Laboratory Technology
关键词 人乳头瘤病毒 聚合酶链反应 反向探针杂交 基因型 Human papillomavirus Polymerase chain reaction Reverse dot blot Genotype
  • 相关文献

参考文献7

二级参考文献27

  • 1王玉琼,龙德蓉,陈凤琼.宫颈癌术后患者恢复自主排尿功能方法的探讨[J].中华护理杂志,2004,39(6):474-475. 被引量:81
  • 2李从铸,翟玉霞.宫颈癌年轻化及其治疗模式的临床研究[J].癌变.畸变.突变,2005,17(1):36-38. 被引量:21
  • 3刘彬,陈汶,任生达,刘新伏,马俊飞,崔剑峰,王秀荣,陈凤,乔友林.液基细胞学剩余标本筛查子宫颈病变中人乳头状瘤病毒DNA的应用[J].中华检验医学杂志,2005,28(5):495-497. 被引量:18
  • 4Mtmoz N, Bosch FX, Sanjose S, et al. Epidermiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med,2003,348:518-527.
  • 5Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol, 1990,75 : 131-133.
  • 6WHO IARC. Carcinogenicity of human papillomaviruses. Lancet Oncology, 2005,6 : 204 -204.
  • 7Komegay JR, Roger M, Davies PO, et al. International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA : evaluation of accuracy and intralaboratory and interlaboratory agreement. J Clin Microbial,2003,41 : 1080-1086.
  • 8Striekler H, Shah K. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance :baseline results from a randomized trial. J Natl Cancer Inst, 2001,93:951-952.
  • 9Nicolas FS, Audrea T, Eliane, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer, 2003,103 :519-524.
  • 10Cai HB, Ding XH, Chen CC. Prevalence of single and multipie human papillomavirus types in cervical cancer and precursor lesions in Hubei, China[J]. Oncology,2009,76:157-161.

共引文献193

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部